Literature DB >> 23816097

Cryotechnology for staged removal of self-expandable metallic airway stents.

Adnan Majid1, Atul Palkar, Renelle Myers, Robert L Berger, Erik Folch.   

Abstract

Self-expandable covered metallic airway stents (SEMAS) deployed for relieving inoperable central airway obstruction frequently develop complications that require removal of the device. Current techniques for SEMAS removal also involve serious complications. We are reporting a novel two-staged endoscopic approach using cryotechnology for removal of SEMAS obstructed by exuberant granulation tissue in two patients. During the first stage, the obstructing intraluminal granulation tissue was removed with cryodebridement and residual extraluminal deposits were lysed with cryotherapy. During the second stage, performed two days later, the SEMAS was liberated by mechanical means and removed in one piece. The staged approach with cryotechnology was successful and without complications.
Copyright © 2013 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23816097     DOI: 10.1016/j.athoracsur.2013.03.002

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  3 in total

1.  Airway stents.

Authors:  Erik Folch; Colleen Keyes
Journal:  Ann Cardiothorac Surg       Date:  2018-03

Review 2.  From electrocautery, balloon dilatation, neodymium-doped:yttrium-aluminum-garnet (Nd:YAG) laser to argon plasma coagulation and cryotherapy.

Authors:  Ashutosh Sachdeva; Edward M Pickering; Hans J Lee
Journal:  J Thorac Dis       Date:  2015-12       Impact factor: 2.895

3.  Spondylodiscitis and spinal epidural abscess related to long-term placement of an airway stent for malignant central airway obstruction.

Authors:  Kohei Shikano; Daisuke Ishii; Tomotaka Umimura; Shintaro Rakuman; Satoshi Maki; Hajime Kasai; Sumihisa Orita; Shunichiro Iwasawa; Toshihiko Sugiura; Seiji Ohtori; Koichiro Tatsumi
Journal:  Thorac Cancer       Date:  2020-06-24       Impact factor: 3.500

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.